WealthPLAN Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-4,350
Closed -$253K – 363
2021
Q1
$253K Buy
4,350
+276
+7% +$15.3K 0.02% 289
2020
Q4
$229K Sell
4,074
-2,184
-35% -$114K 0.02% 300
2020
Q3
$332K Buy
6,258
+444
+8% +$21.5K 0.03% 237
2020
Q2
$286K Buy
5,814
+732
+14% +$31.3K 0.03% 251
2020
Q1
$218K Buy
+5,082
New +$214K 0.03% 226
2016
Q3
$5.91K Sell
246
-246
-50% -$5.85K ﹤0.01% 686
2016
Q2
$5.56K Buy
+492
New +$10.7K ﹤0.01% 1946

Other funds holding IHI

WealthPLAN Partners's IHI Position: Q2 2021 in Review

WealthPLAN Partners sold out of iShares US Medical Devices ETF (IHI) in Q2 2021, closing a stake of 4,350 shares — an estimated $253K sold.

WealthPLAN Partners first reported a position in IHI in Q2 2016 and held it in 7 quarters. The position peaked at $332K in Q3 2020. 559 funds tracked by Wall St. Rank hold IHI as of Q2 2021.

  • WealthPLAN Partners reported no remaining iShares US Medical Devices ETF position as of Q2 2021 after selling out during the quarter.
  • WealthPLAN Partners sold 4,350 iShares US Medical Devices ETF shares in Q2 2021, an estimated $253K.
  • WealthPLAN Partners first reported a position in iShares US Medical Devices ETF in Q2 2016 and held it in 7 quarters.
  • WealthPLAN Partners's iShares US Medical Devices ETF position peaked at $332K in Q3 2020.
  • 559 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2021.

Based on WealthPLAN Partners's 13F filing for Q2 2021, filed 19 Aug 2021.